Genmab — Juni 2019

[E_L]

CyBorD DARA in Blood Advances - http://www.bloodadvances.org/content/3/12/1815?sso-checked=true

[E_L]

@Bulder more on that macrophage activation

[E_L]

this will be the follow up trial https://www.myeloma-europe.org/trials/emn-18/ https://clinicaltrials.gov/ct2/show/NCT03896737

[Bulder]

Interesting to see whether it's even more efficacious than the Cassiopeia combo.

[E_L]

ANDROMEDA https://twitter.com/MM_Hub/status/1139913117272555520

[E_L]

a few more CASSIOPEIA slides https://twitter.com/MM_Hub/status/1139912006511800320

[E_L]

ADCT-301
https://twitter.com/graham74GC/status/1139849029637083136

[E_L]

Just a moment...

(onlinelibrary.wiley.com)

[Solsen]

Impressive responses - hope sideeffects are acceptable. 3 CR after discontinuation are also impressive. Thanks EL !

[Solsen]

ANDROMEDA looks very good too !

[mobbyduck1]

ANDROMEDA looks fantastic, how can
we ask for more??

[transalp]

WAAUH.. ANDROMEDA..

[nohope]

Føler jeg går glip af et eller andet....

[Sukkeralf]

Angående BergenBio så er jeg også sikker på at faldet primært skyldes emissionen:

[Sukkeralf]

NewsWeb

(newsweb.oslobors.no)

[Sukkeralf]

Man kan mene hvad man vil om forløbet (og ja jeg er ikke begejstret), men nu bør der ligge en bund i 13,50.

[Sukkeralf]

Tolero kommer med data fra deres AXL inhibitor på EHA og præsenterede også flotte data i AML med deres CDK9 inhibitor:

[Sukkeralf]

Just a moment...

(www.firstwordpharma.com)

[bibob]

Mere AML. https://www.onclive.com/conference-coverage/eha-2019/new-macrophage-immune-checkpoint-strategy-shows-promise-in-aml-and-mds

[Bulder]

Tak, bibob. Mere makrofag-aktivering. Lidt anderledes virkemåde end dara-cyclo i MM, som vi så forleden, men resultatet er det samme.